Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles

Dong Eog Kim, Jeong Yeon Kim, In Cheol Sun, Dawid Schellingerhout, Su Kyoung Lee, Cheol Hee Ahn, Ick Chan Kwon, Kwang Meyung Kim

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective Advancing the understanding and management of thromboembolic stroke requires simple and robust new methods that would be useful for the in vivo assessment of thrombus burden/distribution and for characterizing its evolution in a prompt and quantitative manner. Methods Animals (n=127) with experimental models of thrombosis were imaged with microcomputed tomography 5 minutes (and/or ∼3 weeks) after intravenous injection of glycol chitosan (GC) gold nanoparticles (AuNPs). Results Nanoparticles accumulated in the thrombus, allowing computed tomography visualization of both the presence and extent of primary and recurrent thrombi in mouse carotid arteries without a single failure of detection. Nanoparticle thrombus imaging was also effective in monitoring the therapeutic efficacy of thrombolysis (n=118 tissue plasminogen activator [tPA] therapies). Thrombus evolution (either spontaneous or post-tPA) could be mapped at high resolution in both space and time. Due to a long circulating half-life, GC-AuNPs remain available for entrapment into fibrin matrix for an extended period of time (up to 3 weeks), allowing repetition or ongoing monitoring of thrombogenesis and thrombolysis. Interpretation This is the first report on a hyperacute direct thrombus imaging technique using thrombus-seeking AuNPs and computed tomography. When translated into stroke practice, the thrombus imaging may allow us to advance to personalized thrombolytic therapy by demonstrating thrombus burden, distribution, and character in a prompt and quantitative manner. Further study into this area is indicated. ANN NEUROL 2013;73:617-625

Original languageEnglish
Pages (from-to)617-625
Number of pages9
JournalAnnals of Neurology
Volume73
Issue number5
DOIs
Publication statusPublished - 2013 May 1
Externally publishedYes

Fingerprint

Gold
Nanoparticles
Thrombosis
Tomography
Thrombolytic Therapy
Tissue Plasminogen Activator
Stroke
X-Ray Microtomography
Fibrin
Carotid Arteries
Intravenous Injections
Half-Life
Theoretical Models

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Kim, D. E., Kim, J. Y., Sun, I. C., Schellingerhout, D., Lee, S. K., Ahn, C. H., ... Kim, K. M. (2013). Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. Annals of Neurology, 73(5), 617-625. https://doi.org/10.1002/ana.23849

Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. / Kim, Dong Eog; Kim, Jeong Yeon; Sun, In Cheol; Schellingerhout, Dawid; Lee, Su Kyoung; Ahn, Cheol Hee; Kwon, Ick Chan; Kim, Kwang Meyung.

In: Annals of Neurology, Vol. 73, No. 5, 01.05.2013, p. 617-625.

Research output: Contribution to journalArticle

Kim, DE, Kim, JY, Sun, IC, Schellingerhout, D, Lee, SK, Ahn, CH, Kwon, IC & Kim, KM 2013, 'Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles', Annals of Neurology, vol. 73, no. 5, pp. 617-625. https://doi.org/10.1002/ana.23849
Kim DE, Kim JY, Sun IC, Schellingerhout D, Lee SK, Ahn CH et al. Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. Annals of Neurology. 2013 May 1;73(5):617-625. https://doi.org/10.1002/ana.23849
Kim, Dong Eog ; Kim, Jeong Yeon ; Sun, In Cheol ; Schellingerhout, Dawid ; Lee, Su Kyoung ; Ahn, Cheol Hee ; Kwon, Ick Chan ; Kim, Kwang Meyung. / Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. In: Annals of Neurology. 2013 ; Vol. 73, No. 5. pp. 617-625.
@article{e2de73ea684c4647a308d7734e8ea9ad,
title = "Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles",
abstract = "Objective Advancing the understanding and management of thromboembolic stroke requires simple and robust new methods that would be useful for the in vivo assessment of thrombus burden/distribution and for characterizing its evolution in a prompt and quantitative manner. Methods Animals (n=127) with experimental models of thrombosis were imaged with microcomputed tomography 5 minutes (and/or ∼3 weeks) after intravenous injection of glycol chitosan (GC) gold nanoparticles (AuNPs). Results Nanoparticles accumulated in the thrombus, allowing computed tomography visualization of both the presence and extent of primary and recurrent thrombi in mouse carotid arteries without a single failure of detection. Nanoparticle thrombus imaging was also effective in monitoring the therapeutic efficacy of thrombolysis (n=118 tissue plasminogen activator [tPA] therapies). Thrombus evolution (either spontaneous or post-tPA) could be mapped at high resolution in both space and time. Due to a long circulating half-life, GC-AuNPs remain available for entrapment into fibrin matrix for an extended period of time (up to 3 weeks), allowing repetition or ongoing monitoring of thrombogenesis and thrombolysis. Interpretation This is the first report on a hyperacute direct thrombus imaging technique using thrombus-seeking AuNPs and computed tomography. When translated into stroke practice, the thrombus imaging may allow us to advance to personalized thrombolytic therapy by demonstrating thrombus burden, distribution, and character in a prompt and quantitative manner. Further study into this area is indicated. ANN NEUROL 2013;73:617-625",
author = "Kim, {Dong Eog} and Kim, {Jeong Yeon} and Sun, {In Cheol} and Dawid Schellingerhout and Lee, {Su Kyoung} and Ahn, {Cheol Hee} and Kwon, {Ick Chan} and Kim, {Kwang Meyung}",
year = "2013",
month = "5",
day = "1",
doi = "10.1002/ana.23849",
language = "English",
volume = "73",
pages = "617--625",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles

AU - Kim, Dong Eog

AU - Kim, Jeong Yeon

AU - Sun, In Cheol

AU - Schellingerhout, Dawid

AU - Lee, Su Kyoung

AU - Ahn, Cheol Hee

AU - Kwon, Ick Chan

AU - Kim, Kwang Meyung

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Objective Advancing the understanding and management of thromboembolic stroke requires simple and robust new methods that would be useful for the in vivo assessment of thrombus burden/distribution and for characterizing its evolution in a prompt and quantitative manner. Methods Animals (n=127) with experimental models of thrombosis were imaged with microcomputed tomography 5 minutes (and/or ∼3 weeks) after intravenous injection of glycol chitosan (GC) gold nanoparticles (AuNPs). Results Nanoparticles accumulated in the thrombus, allowing computed tomography visualization of both the presence and extent of primary and recurrent thrombi in mouse carotid arteries without a single failure of detection. Nanoparticle thrombus imaging was also effective in monitoring the therapeutic efficacy of thrombolysis (n=118 tissue plasminogen activator [tPA] therapies). Thrombus evolution (either spontaneous or post-tPA) could be mapped at high resolution in both space and time. Due to a long circulating half-life, GC-AuNPs remain available for entrapment into fibrin matrix for an extended period of time (up to 3 weeks), allowing repetition or ongoing monitoring of thrombogenesis and thrombolysis. Interpretation This is the first report on a hyperacute direct thrombus imaging technique using thrombus-seeking AuNPs and computed tomography. When translated into stroke practice, the thrombus imaging may allow us to advance to personalized thrombolytic therapy by demonstrating thrombus burden, distribution, and character in a prompt and quantitative manner. Further study into this area is indicated. ANN NEUROL 2013;73:617-625

AB - Objective Advancing the understanding and management of thromboembolic stroke requires simple and robust new methods that would be useful for the in vivo assessment of thrombus burden/distribution and for characterizing its evolution in a prompt and quantitative manner. Methods Animals (n=127) with experimental models of thrombosis were imaged with microcomputed tomography 5 minutes (and/or ∼3 weeks) after intravenous injection of glycol chitosan (GC) gold nanoparticles (AuNPs). Results Nanoparticles accumulated in the thrombus, allowing computed tomography visualization of both the presence and extent of primary and recurrent thrombi in mouse carotid arteries without a single failure of detection. Nanoparticle thrombus imaging was also effective in monitoring the therapeutic efficacy of thrombolysis (n=118 tissue plasminogen activator [tPA] therapies). Thrombus evolution (either spontaneous or post-tPA) could be mapped at high resolution in both space and time. Due to a long circulating half-life, GC-AuNPs remain available for entrapment into fibrin matrix for an extended period of time (up to 3 weeks), allowing repetition or ongoing monitoring of thrombogenesis and thrombolysis. Interpretation This is the first report on a hyperacute direct thrombus imaging technique using thrombus-seeking AuNPs and computed tomography. When translated into stroke practice, the thrombus imaging may allow us to advance to personalized thrombolytic therapy by demonstrating thrombus burden, distribution, and character in a prompt and quantitative manner. Further study into this area is indicated. ANN NEUROL 2013;73:617-625

UR - http://www.scopus.com/inward/record.url?scp=84878312414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878312414&partnerID=8YFLogxK

U2 - 10.1002/ana.23849

DO - 10.1002/ana.23849

M3 - Article

C2 - 23495101

AN - SCOPUS:84878312414

VL - 73

SP - 617

EP - 625

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 5

ER -